Items where Author is "Goeppner, Daniela"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 5.

Article

Forschner, Andrea and Kaehler, Katharina C. and Gschnell, Martin and Langan, Ewan A. and Weishaupt, Carsten and Meiss, Frank and Thoms, Kai-Martin and Wahl, Renate U. and Goeppner, Daniela and Garzarolli, Marlene and Sachse, Michael and Schlaak, Max and Reitmajer, Markus and Kellner, Ivonne and Gesierich, Anja and Mohr, Peter and Meier, Friedegund and von Wasielewski, Imke and Herbst, Rudolf and Utikal, Jochen and Pfoehler, Claudia and Ulrich, Jens and Terheyden, Patrick and Kaatz, Martin and Haferkamp, Sebastian and Leiter, Ulrike and Ugurel, Selma and Weichenthal, Michael and Berking, Carola and Gutzmer, Ralf and Schadendorf, Dirk and Nanz, Lena and Loquai, Carmen (2025) Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. FRONTIERS IN IMMUNOLOGY, 16: 1509886. ISSN 1664-3224,

Heppt, Markus V. and Heinzerling, Lucie and Kaehler, Katharina C. and Forschner, Andrea and Kirchberger, Michael C. and Loquai, Carmen and Meissner, Markus and Meier, Friedegund and Terheyden, Patrick and Schell, Beatrice and Herbst, Rudolf and Goeppner, Daniela and Kiecker, Felix and Rafei-Shamsabadi, David and Haferkamp, Sebastian and Huber, Margit A. and Utikal, Jochen and Ziemer, Mirjana and Bumeder, Irmgard and Pfeiffer, Christiane and Schaed, Susanne G. and Schmid-Tannwald, Christoph and Tietze, Julia K. and Eigentler, Thomas K. and Berking, Carola (2017) Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. EUROPEAN JOURNAL OF CANCER, 82. pp. 56-65. ISSN 0959-8049, 1879-0852

Conference or Workshop Item

Schadendorf, Dirk and Richtig, Erika and Loquai, Carmen and Forschner, Andrea and Gutzmer, Ralf and Haferkamp, Sebastian and Utikal, Jochen and Hassel, Jessica Cecile and Meier, Friedegund and Debus, Dirk and Fluck, Michael and Goeppner, Daniela and Kehrer, Helmut and Dummer, Reinhard and von Moos, Roger and Thompson, Jan and Gengenbacher, Laura and Michielin, Olivier and Hoeller, Christoph (2022) Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: an ongoing multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERING-Melanoma. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Richtig, Erika and Gutzmer, Ralf and Loquai, Carmen and Utikal, Jochen and Hoeller, Christoph and Stadler, Rudolf and Forschner, Andrea and Hassel, Jessica Cecile and Goeppner, Daniela and Fluck, Michael and Haferkamp, Sebastian and Kaatz, Martin and Welslau, Manfred and Dummer, Reinhard and Von Moos, Roger Anton Fredy and Schmidt, Andrea and Milde, Laura and Michielin, Olivier and Schadendorf, Dirk (2021) Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600)-mutant melanoma: First data of the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA). In: 2021 ASCO Annual Meeting, 4. Juni - 8. Juni 2021, Online.

Schadendorf, Dirk and Eigertler, Thomas and Mohr, Peter and Weichenthal, Michael and Goeppner, Daniela and Haferkamp, Sebastian and Herber, Martin and Meier, Friedegund and Meiss, Frank and Pfoehler, Claudia and Schneider, Stefan W. and Terheyden, Patrick and Ulrich, Lens and Utikal, Jochen and Weishaupt, Carsten and Gutzmer, Ralf (2020) Nico: Real World Evidence in Advanced Melanoma; A National Prospective Non-Interventional Study of Nivolumab Monotherapy or in Combination with Ipilimumab in Patients with Advanced Melanoma and in Patients with Adjuvant Nivolumab Therapy. In: 34. Deutscher Krebskongress (DKK), 19.-22. Februar 2020, Berlin.

This list was generated on Fri Mar 27 11:46:03 2026 CET.